Skip to main content

Harmony Biosciences Holdings, Inc.

HRMY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001802665

In the last 90 days, Harmony Biosciences Holdings, Inc. insiders filed 0 open-market purchases and 2 sales; 328 institutions reported holding it in 13F filings for Q2 2026, worth $1.97B in total; no superinvestor holds it.

Holders of 5% or more of HRMY

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Harmony Biosciences Holdings, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of HRMY
HolderLatest formStakeChangeFirst filedLatest filingFiling
BlackRock, Inc.13G/A11.30%6.53M shares+1.20 ppfrom 10.10%Feb 5, 20253 filingsJul 28, 2026SEC
Marshman Fund Trust II13G/A10.60%6.05M shares–Jan 29, 20212 filingsFeb 10, 2025SEC
FMR LLC13G/A5.40%3.11M shares−1.30 ppfrom 6.70%Feb 8, 20215 filingsFeb 5, 2026SEC
Vanguard Portfolio Management LLC13G5.08%2.94M sharesNewJul 31, 20261 filingJul 31, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

24 Schedule 13D and 13G filings on Harmony Biosciences Holdings, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on HRMY
Filed (ET)FilerFormStakeChangeEvent dateFiling
Jul 31, 202611:23 AM ETVanguard Portfolio Management LLC13G5.08%2.94M sharesNewJun 30, 2026SEC
Jul 28, 20264:44 PM ETBlackRock, Inc.13G/A11.30%6.53M shares+1.20 ppfrom 10.10%Jun 30, 2026SEC
Mar 27, 20269:32 AM ETVanguard Group Inc13G/A0.00%0 shares−8.30 ppfrom 8.30%Below 5%Mar 13, 2026SEC
Feb 5, 20261:28 PM ETFMR LLCand 1 other13G/A5.40%3.11M shares−1.30 ppfrom 6.70%Dec 31, 2025SEC
Nov 14, 20255:03 PM ETValor IV Pharma Holdings, LLCand 8 others13G/A3.20%1.83M shares−8.50 ppfrom 11.70%Below 5%Sep 30, 2025SEC
Nov 5, 202511:35 AM ETFMR LLCand 1 other13G/A6.70%3.85M shares–Sep 30, 2025SEC
Apr 29, 20252:47 PM ETBlackRock, Inc.13G/A10.10%5.77M shares−2.10 ppfrom 12.20%Mar 31, 2025SEC
Feb 12, 20256:10 PM ETValor IV Pharma Holdings, LLCand 8 others13G/A11.70%6.65M shares–Dec 31, 2024SEC
Feb 10, 20254:30 PM ETMarshman Fund Trust II13G/A10.60%6.05M shares–Dec 31, 2024SEC
Feb 5, 20251:23 PM ETBlackRock, Inc.13G/A12.20%6.97M shares–Dec 31, 2024SEC
Jan 30, 20259:57 PM ETVanguard Group Inc13G/A8.30%4.73M shares–Dec 31, 2024SEC
Feb 14, 2022venBio Global Strategic Fund II L.P.13G/AOld format–––SEC
Feb 11, 2022Vivo Capital VIII, LLC13G/AOld format–––SEC
Feb 11, 2022HBM Healthcare Investments (Cayman) Ltd.13G/AOld format–––SEC
Feb 10, 2022Valor IV Pharma Holdings, LLC13G/AOld format–––SEC
Feb 9, 2022FMR LLC13G/AOld format–––SEC
Jul 12, 2021FMR LLC13G/AOld format–––SEC
May 21, 2021Novo Holdings A/S13G/AOld format–––SEC
Feb 16, 2021Valor IV Pharma Holdings, LLC13GOld format–New–SEC
Feb 16, 2021venBio Global Strategic Fund II L.P.13GOld format–New–SEC
Feb 12, 2021HBM Healthcare Investments (Cayman) Ltd.13GOld format–New–SEC
Feb 8, 2021Novo Holdings A/S13G/AOld format–––SEC
Feb 8, 2021FMR LLC13G/AOld format–––SEC
Jan 29, 2021Marshman Fund Trust II13GOld format–New–SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Harmony Biosciences Holdings, Inc. shares.

No Form 144 notices for Harmony Biosciences Holdings, Inc. are on file.